Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yoshirou NITTA"'
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 65:1136-1143
The effect of sparfloxacin (SPFX) on fecal microflora and its fecal concentrations were examined in four patients and one carrier with bacillary dysentery. SPEX was administered to five cases with a daily dose of 200 mg, once a day, for five days aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1774a7d52e2f010947e65e794ce073c4
https://doi.org/10.11150/kansenshogakuzasshi1970.65.1136
https://doi.org/10.11150/kansenshogakuzasshi1970.65.1136
Autor:
Takakazu AOKI, Yoshio MATSUBARA, Hiroko SAGARA, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshirou NITTA, Takehisa SEO, Makoto KAMIMURA, Gohta MASUDA, Masayoshi NEGISHI, Shinten YO, Yatsuka IMAGAWA, Kenji OHNISHI, Kazue SAKU, Nagayo SHIMIZU, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichro HOSOYA, Jyuji HOSHINO, Fukiko AMANO, Chie NAKAMURA, Akira MURAMOTO, Yoshio KOBAYASHI, Ryuki KIN, Chihiro IMAI, Mitsuru AKAO, Akio TODO, Katsuhiko FUJIMI, Tadakazu AISAKA, Masanobu NIIMI, Toshiko MATSUO, Makoto SAITO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Yoshio INAGAKI, Hideko TAKANO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 63:593-605
For the purpose of evaluation of clinical efficacy, safety and usefulness on acute infectious enteritis (bacillary dysentery, and enteritis caused by Salmonella spp., Campylobacter spp., enteropathogenic E. coli, and so on), T-3262, a newly developed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32cca7359e454ed078485bac8cee6439
https://doi.org/10.11150/kansenshogakuzasshi1970.63.593
https://doi.org/10.11150/kansenshogakuzasshi1970.63.593
Autor:
Takakazu AOKI, Yoshio MATSUBARA, Hiroko SAGARA, Nagayo SHIMIZU, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshirou NITTA, Takehisa SEO, Makoto KAMIMURA, Naoko KANEHISA, Gohta MASUDA, Masayoshi NEGISHI, Shinten YO, Yatsuka IMAGAWA, Kenji OHNISHI, Kazue SAKU, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichiro HOSOYA, Jyuji HOSHINO, Fukiko AMANO, Chie NAKAMURA, Akira MURAMOTO, Yoshio KOBAYASHI, Ryuki KIN, Chihiro IMAI, Mitsuru AKAO, Akio TODO, Katsuhiko FUJIMI, Tadakazu AISAKA, Masanobu NIIMI, Toshiko MATUO, Makoto SAITO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Yoshio INAGAKI, Hideko TAKANO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 63:659-675
For the purpose of evaluation of clinical efficacy, safety and usefulness on Salmonella enteritis, T-3262 (Tosufloxacin tosilate), a newly developed pyridone-carboxylic acid derivative, was administered to a total of 103 patients and carriers. In add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45e3852bc8025546df86ed04b79ebee
https://doi.org/10.11150/kansenshogakuzasshi1970.63.659
https://doi.org/10.11150/kansenshogakuzasshi1970.63.659